Research Article: Heterogeneity of ?? T-cell subsets and their clinical correlation in patients with AML
Abstract:
Background: ?? T cells are integral elements of the immune system and have shown therapeutic potential in the treatment of acute myeloid leukemia (AML). Nevertheless, the influence of distinct functional subsets, including the activating marker NKG2D, the immune exhaustion marker TIGIT, and the regulatory marker Foxp3, on therapeutic outcomes in AML patients remains unknown.
No summary available.